Construction and expression of gastric cancer MG7 mimic epitope fused to heat shock protein 70

World Chinese Journal of Digestology

Volumn 9, Issue 8, 2001, Pages 892-896

  Ning, X X ^a   Wu, K C ^a   Shi, Y Q ^a   Wang, X ^a   Zhao, Y Q ^a   Fan, D M ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antigen, neoplasm genetics; Epitopes; Gene expression; Heat shock proteins 70 genetics; Stomach neoplasms immunology

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ARTICLE; EPITOPE MAPPING; FUSION GENE; HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; STOMACH CANCER;

EID: 0034882040     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Biological therapy on esophageal carcinoma
2. Clinical research of hepatocellular carcinoma in the 21st century
3. Studies on surgical operations and prognosis of extrahepatic bile duct cancer
4. Effect of remedies of supporting resistance and relieving blood stasis on metastasis of post-operative gastric cancer and ornithine decarboxylase
5. Stage II surgical resection of hepatocellular carcinoma after TAE: A report of 38 cases
6. Clinical research advances in primary liver cancer
7. Clinical study on surgical treatment of esophageal carcinoma in patients after subtotal gastrectomy
8. Surgical treatment of residual stomach cancer with a new technique of alimentary tract reconstruction
9. Diagnosis and treatment of malignant leioblastoma of small intestine
10. Resection of gastric carcinoma with preservation of pancreas and clearance of lymph nodes along splenic artery: Theory, technique and results
11. Surgical resection for hepatoportal bile duct cancer
12. A clinical and long-term follow-up study of peri-operative sequential triple therapy for gastric cancer
13. Biological significance of serum soluble tumor necrosis factor receptor I in hepatoma patients
14. Radiotherapy of double primary esophageal carcinoma
15. Evolution of gastrointestinal double contrast radiography in China: Researches, application and popularization
16. A study of preoperative methionine-depleting parenteral nutrition plus chemotherapy in gastric cancer patients
17. Prevention of metastasis to liver by using 5-FU intraperitoneal chemotherapy in nude mice inoculated with human colonic cancer cells
18. Hepatic arterial infusion chemotherapy embolization in the treatment of primary hepatic carcinoma
19. An investigation of intra-arterial chemotherapy infusion and embolization combined with abdominal chemotherapy for advanced gastric cancer
20. The value of postoperative hepatic regional chemotherapy in prevention of recurrence after radical resection of primary liver cancer
21. Bioinformatics and protein modelling of the GS element of Mycobacterium avium subsp. paratuberculosis (MAP) and GS-encoded proteins as drug targets and vaccine components
22. Immuno-protective effect of tumor cell vaccine on Kunming mice bearing Ehrlich ascites tumor
23. Further characterization of a clinically relevant model of melanoma metastasis and an effective vaccine
24. Tumor vaccination
25. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens
26. Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines
27. Recombinant virus vaccination against "self" antigens using anchor-fixed immunogens
28. Development of a retrovirus-based complementary DNA expression system for the cloning of tumor antigens
29. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo
30. DNA vaccination prevents and/or delays carcinoma development of papillomavirus-induced skin papillomas on rabbits
31. Construction and immunogenicity of DNA vaccine plasmids encoding four Plasmodium vivax candidate vaccine antigens
32. A transgenic mouse model for turnout immunotherapy: Induction of an anti-idiotype response to human MUC1
33. Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen
34. Murine and human monoclonal antibodies against gastric cancer
35. A novel gastric cancer related glycolipid glycoprotein antigen
36. Protein antigenic structures recognized by T cells: Potential applications to vaccine design
37. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics
38. Trick and treat: Toward peptide mimic vaccines
39. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens
40. Generation of antigen specific CD8 + cytotoxic T cells following inmunization with soluble protein formulated with novel glycoside adjuvants
41. The importance of exogenous antigen in priming the human CD8 + T cell response: Lessons from the EBV nuclear antigen EBNA1
42. Induction of an antigen-specific CTL response by a conformationally biased agonist of human C5a anaphylatoxin as a molecular adjuvant
43. Processing of bacterial antigens for peptide presentation on MHC class I molecules
44. The adjacent flanking region plays a critical role in facilitating the presentation of the Listeria monocytogenes product lemA to H2 M3wt-restricted, peptide-specific murine CD8 cells
45. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor-and peptide-specific immunity
46. A recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Thl immune response without adjuvant
47. Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein
48. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways
49. MHC class I- restricted CTL responses to exogenous antigens
50. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells
51. The Hsp90 chaperone complex - A poteitial target for cancer therapy?
52. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations
53. Heat shock proteins, tumor immunogenicity and antigen presentation: An integrated view
54. Tumor secreted heat shock-fusion protein elicits CD8 cells for rejection
55. Stress protein/peptide complexes derived from autologous tumor tissue as tumor vaccines
56. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90 and hsp70
57. Generation of cytotoxic T lymphcytes induced with HSP-PC70 derived from tumor cells
58. Purification of hsp70 and its immunoprotective effect against mouse hepatoma
59. Heat shock protein 70-associated peptides elicit specific cancer immunity
60. Synthetic peptides non-covalently bound to bacterial hsp70 elicit peptide-specific T-cell responses in vivo
61. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity
62. In vivo cytotoxic T lymphocyte elicitation by mycobacterial heat shock protein 70 fusion proteins maps to a discrete domain and is CD4 + T cell independent
63. Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes
64. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway
65. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24
66. A proposed mechanism for the induction of cytotoxic T lymphocyte production by heat shock fusion proteins
67. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene
68. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer
69. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides
70. Mycobacterial heat-shock proteins as carrier molecules
71. Heat shock proteins in immune response to cancer: The fourth paradigm
72. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells
73. Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70
74. Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules
75. Exogenous antigen targeted to FcgammaRI on myeloid cells is presented in association with MHC class I